Polycystic ovary syndrome (PCOS) is characterized by chronic unovulation, hyperandrogenism, and insulin resistance. We evaluated factors that affect “nondipper” status during 24-hour ambulatory blood pressure monitoring (ABPM) and carotid intima-media thickness (cIMT) in PCOS. Forty-two nonobese women newly diagnosed as PCOS and 32 healthy women were included. After biochemical and hormonal measurements, the ovaries were imaged by pelvic ultrasonography and cIMT was measured by B-mode ultrasonography. A 24-hour ABPM was performed thereafter. Carotid IMT and the ratio of nondippers were elevated compared with controls. Homeostasis model assessment insulin resistance index (HOMA-IR) and low-density lipoprotein cholesterol (LDL-C) were found to be related with being a nondipper in PCOS. None of the parameters evaluated were found to correlate with cIMT. In conclusion, patients with PCOS had increased nondipping ratios and cIMT when compared with controls. Insulin resistance and LDL cholesterol are factors that are related to diurnal variation in normotensive and young patients with PCOS.
TeedeHDeeksAMoranL. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;30(8):41.
2.
DeUgarteCMBartolucciAAAzzizR. Prevalance of insulin resistance in polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454–1460.
3.
DokrasABochnerMHollinrakeEMarkhamSVanvoorhisBJagasiaDH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106(1):131–137.
4.
EltingMWKorsenTJShoemakerJ. Obesity rather than menstrual cycle pattern or follicule cohort size determines hyperinsulinemia, dyslipidemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endorcinol. 2001;55(6):767–776.
5.
DunaifA. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for athogenesis. Endocr Rev. 1997;18(6):774–800.
6.
LegroRSKunselmanARDunaifA. Prevalance and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111(8):607–613.
7.
YildizBOHaznedarogluICKirazliSBayraktarM. Global fibrinolytic capacity is decreased in polycystic ovary syndrome suggesting a prothrombic state. J Clin Endocrinol Metab. 2002;87(8):3871–3875.
8.
Diamanti-KandrakisEPalionikoGAlexandrakiKBergieleAKoutsoubaTBartzisM. The prevalance of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endorcinol. 2004;150(6):793–798.
9.
ParadisiGSteinbergHOHempflingA. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410–1415.
10.
YaraliHYildirirAAybarF. Diastolic dysfunction and increased homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76(3):511–516.
11.
EhrrmanDA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–1236.
12.
MitchellJRSchwartzCJ. Relationship between arterial disease in different sites: a study of aorta and coronary, carotid, and iliac arteries. Br Med J. 1962;1(5288):1293–1301.
13.
HodisHMackWLaBreeL. The role of carotid arterial intima media thickness in predicting clinical coronary events. Ann Int Med. 1998;128(4):262–269.
14.
TalbottEGuzickDSSutton-TyrrellK. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle aged women. Arterioscler Thromb Vasc Biol. 2000;20(11):2414–2421.
15.
CascellaTPalombaSTauchmanovaL. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(11):4395–4400.
16.
ChenMJYangWSYangJHChenCLHoHNYangYS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension. 2007;49(6):1442–1447.
17.
de la SierraASeguraJGorostidiMBanegasJRde la CruzJJRuilopeLM. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res. 2010;33(8):767–771.
18.
RoutledgeFSMcFetridge-DurdleJADeanCR. Canadian Hypertension Society. Nighttime blood pressure patterns and target organ damage: a review. Can J Cardiol. 2007;23(2):132–138.
19.
HoshideSKarioKHoshideY. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16(6):434–438.
20.
VerdecchiaPSchillaciGGuerrieriM. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81(2):528–536.
21.
The Rotterdam ESHRE/ASRM—Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
22.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
23.
GoodmanNBledsoeMCobinR. American Association of Clinical Endocrinologists Hyperandrogenism Guidelines. Endocr Pract. 2001;7(2):120–134.
24.
TalbottEGuzickDClericiA. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995;15(7):821–826.
25.
DejagerSPichardCGiralP. Smaller LDL particle size in women with PCOS compared to controls. Clin Endocrinol (Oxf). 2001;54(4):455–462.
26.
KellyCCLyallHPetrieJRGouldGWConnellJMSattarN. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455.
27.
LegroRSCastracaneVDKauffmanRP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59(2):141–154.
28.
PasqualiRAntenucciDCasimirriF. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab. 1989;68(1):173–179.
29.
DunaifAHoffmanARScullyRE. Clinical, biochemical and ovarian morphological features in women with acanthosis nigricans and masculinization. Obstet Gynecol. 1985;66(4):545–552.
30.
PoretskyLCataldoNARosenwaksZGiudiceLC. The insulin related ovarian regulatory system in health and disease. Endocr Rev. 1999;20(4):535–582.
31.
PuderJJMullerBBKellerU. Letter re: the biological variation of testosterone and sex-hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab. 2005;90(7):4419–4420.
32.
WallaceTMLevyJCMatthewsDR. Use and abuse of HOMA modelling. Diab Care. 2004;27(6):1487–1495.
33.
DunaifAFinegoodDT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81(3):942–947.
34.
BaillargeonJPCarpentierA. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril. 2007;88(4):886–893.
35.
SozenIAriciA. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstet Gynecol Surv. 2000;55(5):321–328.
36.
AfsarBSezerSElsurerROzdemirFN. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?Blood Press Monit. 2007; 12(3):133–139.
37.
DeyneliOYaziciDToprakA. Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes. Hypertens Res. 2008;31(11):2065–2073.
KayaCOnalanGCengizSD. An increase in systolic blood pressure and abnormal circadian blood pressure regulation in lean women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):217–218.
40.
HolteJGennarelliGBerneCBerghTLithellH. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?. Hum Reprod. 1996;11(1):23–28.
41.
StamatelopoulosKSManiosEBarlasG. Time rate of blood pressure variation is superior to central hemodynamics as an associate of carotid intima-media thickness. J Hypertens. 2010;28(1):51–58.
42.
ZakopoulosNATsivgoulisGBarlasG. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension. 2005;45(4):505–512.
